Alessa Therapeutics, Inc.

Biotechnology company · San Carlos, California, United States

Alessa Therapeutics, Inc. is a biotechnology company headquartered in San Carlos, California, United States. Its earliest recorded incorporation is in 2018. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $799,394 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2025.

www.alessatherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Alessa Therapeutics at a glance

Typebiotechnology company
HeadquartersSan Carlos, California, United States
Earliest incorporation on record2018
Employees (per SBIR records)4
SEC CIK1771653

What does Alessa Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $799,394 in total (2021 to 2023). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $25.4 million sold (2025).

Frequently asked questions about Alessa Therapeutics

Where is Alessa Therapeutics headquartered?

Alessa Therapeutics, Inc. is headquartered in San Carlos, California, United States.

What does Alessa Therapeutics do?

Alessa Therapeutics, Inc. is a biotechnology company.

When was Alessa Therapeutics founded?

The earliest incorporation on record for Alessa Therapeutics, Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.

Alessa Therapeutics: Headquarters, Locations & Company Profile (2026) | BioBridgeX